218 related articles for article (PubMed ID: 12553744)
21. Critical role of L-arginine in endothelial cell survival during oxidative stress.
Suschek CV; Schnorr O; Hemmrich K; Aust O; Klotz LO; Sies H; Kolb-Bachofen V
Circulation; 2003 May; 107(20):2607-14. PubMed ID: 12742995
[TBL] [Abstract][Full Text] [Related]
22. The nitric oxide pathway is amplified in venular vs arteriolar cultured rat mesenteric endothelial cells.
Wagner L; Hoey JG; Erdely A; Boegehold MA; Baylis C
Microvasc Res; 2001 Nov; 62(3):401-9. PubMed ID: 11678642
[TBL] [Abstract][Full Text] [Related]
23. The pivotal role of nitric oxide for vascular health.
Cooke JP
Can J Cardiol; 2004 Aug; 20 Suppl B():7B-15B. PubMed ID: 15309199
[TBL] [Abstract][Full Text] [Related]
24. Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk.
Schlaich MP; Oehmer S; Schneider MP; Delles C; Schmidt BM; Schmieder RE
Atherosclerosis; 2007 May; 192(1):155-60. PubMed ID: 16765359
[TBL] [Abstract][Full Text] [Related]
25. Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Durante W; Johnson FK; Johnson RA
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide and the endothelium: history and impact on cardiovascular disease.
Yetik-Anacak G; Catravas JD
Vascul Pharmacol; 2006 Nov; 45(5):268-76. PubMed ID: 17052961
[TBL] [Abstract][Full Text] [Related]
27. Vascular effects of dietary L-arginine supplementation.
Preli RB; Klein KP; Herrington DM
Atherosclerosis; 2002 May; 162(1):1-15. PubMed ID: 11947892
[TBL] [Abstract][Full Text] [Related]
28. Effects of non-surgical periodontal treatment on the L-arginine-nitric oxide pathway and oxidative status in platelets.
Siqueira MA; Fischer RG; Pereira NR; Martins MA; Moss MB; Mendes-Ribeiro AC; Figueredo CM; Brunini TM
Exp Biol Med (Maywood); 2013 Jun; 238(6):713-22. PubMed ID: 23918883
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.
Rajapakse NW; Nanayakkara S; Kaye DM
Pharmacol Ther; 2015 Oct; 154():1-12. PubMed ID: 25989232
[TBL] [Abstract][Full Text] [Related]
30. Relative contribution of different l-arginine sources to the substrate supply of endothelial nitric oxide synthase.
Karbach S; Simon A; Slenzka A; Jaenecke I; Habermeier A; Martiné U; Förstermann U; Closs EI
J Mol Cell Cardiol; 2011 Nov; 51(5):855-61. PubMed ID: 21839088
[TBL] [Abstract][Full Text] [Related]
31. Novel therapies targeting vascular endothelium.
Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
[TBL] [Abstract][Full Text] [Related]
32. Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.
Li C; Huang W; Harris MB; Goolsby JM; Venema RC
Biochem J; 2005 Mar; 386(Pt 3):567-74. PubMed ID: 15743275
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide bioavailability dysfunction involves in atherosclerosis.
Chen JY; Ye ZX; Wang XF; Chang J; Yang MW; Zhong HH; Hong FF; Yang SL
Biomed Pharmacother; 2018 Jan; 97():423-428. PubMed ID: 29091892
[TBL] [Abstract][Full Text] [Related]
34. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
Dhar I; Dhar A; Wu L; Desai K
J Pharmacol Exp Ther; 2012 Jul; 342(1):196-204. PubMed ID: 22518022
[TBL] [Abstract][Full Text] [Related]
35. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
[TBL] [Abstract][Full Text] [Related]
36. Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of L-[guanidino-(15)N(2)]-arginine to (15)N-labeled nitrate by gas chromatography--mass spectrometry.
Böger RH; Tsikas D; Bode-Böger SM; Phivthong-Ngam L; Schwedhelm E; Frölich JC
Nitric Oxide; 2004 Aug; 11(1):1-8. PubMed ID: 15350551
[TBL] [Abstract][Full Text] [Related]
37. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
[TBL] [Abstract][Full Text] [Related]
38. Effects of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. Evidence for an important role of endothelial production of nitric oxide.
Hiramatsu T; Forbess JM; Miura T; Mayer JE
J Thorac Cardiovasc Surg; 1995 Jan; 109(1):81-6; discussion 87. PubMed ID: 7529348
[TBL] [Abstract][Full Text] [Related]
39. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
Nakai Y; Voisine P; Bianchi C; Xu SH; Feng J; Malik T; Rosinberg A; Sellke FW
Surgery; 2005 Aug; 138(2):291-8. PubMed ID: 16153439
[TBL] [Abstract][Full Text] [Related]
40. L-arginine transporters in cardiovascular disease: a novel therapeutic target.
Chin-Dusting JP; Willems L; Kaye DM
Pharmacol Ther; 2007 Dec; 116(3):428-36. PubMed ID: 17915331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
